MFDS approves ‘Invossa K Inj,’ Korea’s first gene therapy
The Ministry of Food and Drug Safety(MFDS) announced approval of ‘Invossa K Inj,’ a gene therapy for the treatment of osteoarthritis in the knee, on the 12th of July.
Gene therapy is a pharmaceutical product is that is a dielectric substance or has cells whose dielectric substance is transformed...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
